Paradigm Biopharmaceuticals Limited (ASX:PAR)
0.255
0.00 (0.00%)
At close: Mar 6, 2026
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 112.01 million as of March 6, 2026. Its market cap has decreased by -52.06% in one year.
Market Cap
112.01M
Enterprise Value
106.65M
Revenue
8.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 112.01M, an increase of 245.66%. That is a compound annual growth rate of 12.47%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 122.33M |
| Botanix Pharmaceuticals | 128.65M |
| Arovella Therapeutics | 94.16M |
| Recce Pharmaceuticals | 138.81M |
| Alterity Therapeutics | 87.00M |
| Actinogen Medical | 146.60M |
| Cynata Therapeutics | 84.30M |
| LTR Pharma | 81.80M |